Access cutting-edge locally advanced or metastatic her2-expressing cancers treatment through this phase 1/2 clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Duarte location
Preparing your pre-screening questions…
Access locally advanced or metastatic her2-expressing cancers specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related locally advanced or metastatic her2-expressing cancers treatment provided free
Check if you qualify for this locally advanced or metastatic her2-expressing cancers clinical trial in Duarte, CA
No-Cost Study Care
Local to Duarte
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation and dose-expansion study is designed to evaluate the safety, pharmacokinetics, and preliminary activity of VIR-5818 (Formerly AMX-818) as a single agent and in combination with pembrolizumab in participants with HER2+ tumors across multiple tumor types. The study will be conducted in four parts: * Part 1 (dose escalation): Single-agent VIR-5818 * Part 2 (dose escalation): VIR-5818 plus pembrolizumab * Part 3 (dose expansion): Single-agent VIR-5818 * Part 4 (dose expansion): VIR-5818 plus pembrolizumab The total length of the study, from screening of the first participant to the end of the study, is expected to be approximately 72 months.
Sponsor: Vir Biotechnology, Inc.
Yes, this clinical trial (NCT05356741) has an active research site in Duarte, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for locally advanced or metastatic her2-expressing cancers treatment options in Duarte, CA, this clinical trial (NCT05356741) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Duarte research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced locally advanced or metastatic her2-expressing cancers specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all locally advanced or metastatic her2-expressing cancers clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Duarte — not just this study.
Browse Breast Cancer Trials in Duarte →